darolutamide
bayer,orion corp
['darolutamide', 'prostate']
phase 3 #clinicaltrial results presented at #asco22 involving work by dr. cora sternberg ( ) demonstrate improved overall survival + undetectable psa levels in a subset of #prostatecancer patients who received darolutamide + chemo: 
The Weill Cornell Medicine (WCM) Genitourinary (GU) Oncology Program provides cutting-edge care for people with prostate, kidney, bladder & testicular cancers.